Medical device maker Boston Scientific is being hit by a cyberattack. The shares are falling

By America Pulse · Based on reporting from CNBC

Boston Scientific disclosed on Wednesday that a cyberattack this week has disrupted its operations, prompting a decline in the stock of the $72 billion medical‑device company.

Cyberattack Impact on Operations

The intrusion has blocked the firm’s access to internal information systems and applications, including the platforms that manage shipment services. In a filing with the Securities and Exchange Commission, the company said it is working diligently to restore the affected functions, but a timeline for full recovery remains unknown.

Stock Performance

Following the announcement, Boston Scientific’s shares slipped 4.5 percent in early trading on Wednesday. The decline adds to a difficult year for the maker of pacemakers, stents and other devices, whose stock has already been cut nearly in half after a weak first‑quarter profit outlook.

Analyst Insights

Piper Sandler analysts said they spoke with Boston Scientific management on Wednesday morning and expect it may take weeks before normal business resumes. Matt O’Brien of Piper Sandler wrote that the company could be back to shipping all products in under three weeks. He warned that the inability to process and ship orders will likely hurt sales, a concern for a firm already seeing a slowdown in sales growth.

Ongoing Challenges

The cyber incident arrives as Boston Scientific confronts broader market headwinds. Its product portfolio, which includes critical cardiovascular implants, makes any operational interruption especially consequential for patients and healthcare providers. Management is focused on restoring systems and limiting the impact on customers, though a definitive recovery date has not been set.

Future Outlook

The attack represents a notable setback for a company already navigating a challenging environment. How quickly Boston Scientific can reestablish full operational capacity will be pivotal for its upcoming performance. Investors and analysts will monitor the situation closely to gauge the longer‑term effects on the company’s financial health and market position.

Source: CNBC · 2026-08-26